7-BROMO-3-CYANO-4-HYDROXYQUINOLINE, 97.0%, 250mg

Éther diisopropylique, min 98 %, pour la synthèse, stab., 2,5 l, emballage en verre

2,7-Dibromo-3,6-dimethyl-9H-fluorene, 250mg

3-(2,4-Dimethylphenyl)-1,2-oxazol-5-amine, 95%, 1g

2-(4-Bromo-2-fluorophenoxy)acetic acid, 97%, 100mg

5-Hydroxypyrimidine-2-carbonitrile, 97%, 100mg

(6R,7R)-7-Amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 500g

2-(Naphthalen-1-yl)-2-oxoacetic acid, 97%, 1g

DSP Crosslinker, 98.73%, 250mg

2-Chloro-6-fluoroquinazoline, 98%, 500mg

1,3-dihydro-2,1-benzoxaborole-1,5-diol, 95.0%, 500mg

1-Chloro-3-fluoro-2-nitro-5-(trifluoromethyl)benzene, 98%, 5g

5-Chloro-1-phenyl-3-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde, 97.0%, 100mg